Samplix

Samplix has developed a proprietary technology - the Xdrop™ technology – for single molecule sample preparation. At the core of the technology is the generation of millions of droplets formed as “water-oil-water”, each droplet constituting a reaction chamber for the handling of single DNA molecules. The Xdrop™ technology comprises both an instrument and related consumables.

Samplix enables single DNA molecule sample preparation where today only multi-molecule sample preparation is possible. Among many applications, the Xdrop™ technology allows for targeted enrichment of very large DNA fragments.

Samplix addresses customers’ demand for precision, sensitivity and ease of use by overcoming the technical shortcomings of today's technologies.

Samplix headquartered in Europe, operates in the Information Technology, Biotechnology sector. The company focuses on Information Technology and has secured $335.1M in funding across 24 round(s). With a team of 11-50 employees, Samplix is actively contributing to advancements in Information Technology. Their latest funding round, Venture Round - Samplix, raised $8.2M. Discover more about their projects, partnerships, and impact on our platform.